Company: SONM
Filing Date: 2025-07-09
Form Type: S-3
Source: 0001641172-25-018394
Chunk: 2

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-07-09
Form: S-3
Chunk 2
---
.

Up to 1,650,000 Shares of Common Stock

Including up to 550,000 Shares of Common Stock Issuable upon Exercise of Warrants</div>

This prospectus relates to the
resale of up to an aggregate of 1,650,000 shares of our common stock, par value of $0.001 per share, which consists of up to (i)
1,100,000 shares of our common stock (the “May 2025Shares”) and (ii) 550,000 shares of
our common stock issuable upon the exercise of certain common stock purchase warrants (the “Warrants”) with a term
of five (5) years and an exercise price of $1.3864 per share (the “Warrant Shares” and, together with the May
2025 Shares, the “Resale Shares”) by the selling stockholders named in this prospectus and their
permitted transferees (the “Selling Stockholders”). For information about the Selling Stockholders,
see the section titled “Selling Stockholders.”

We are registering the offer
and sale of the Resale Shares originally issued in a private placement pursuant to a registration rights agreement, which we entered
into with the Selling Stockholders on May 12, 2025 (the “Registration Rights Agreement”). The Registration
Rights Agreement was contemplated by that certain subscription agreement between us and the Selling Stockholders entered on May
12, 2025 (the “Subscription Agreement”). Pursuant to the Subscription Agreement, we issued and sold the May
2025 Shares and the Warrants at a price of $1.25 per share of our common stock and the accompanying one-half of a Warrant,
for an aggregate purchase price of $1,375,000. We issued the May 2025 Shares and the Warrants in reliance upon the
exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”),
or Regulation D promulgated thereunder.

We are not selling any shares
of our common stock and will not receive any of the proceeds from the sale of the Resale Shares by the Selling Stockholders, pursuant
to this prospectus; however, we will receive the exercise price to purchase the Warrant Shares upon any cash exercise of the Warrants
by the Selling Stockholders. For information, see the section titled “Use of Proceeds.”

The Resale Shares (assuming the exercise of